Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

围绕GLP-1药物的竞争正从制药领域延伸至药品配送环节。亚马逊（AMZN）近期开始在其药房销售诺和诺德（NVO）的口服GLP-1减肥药Wegovy片剂，这一举措可能对同样涉及相关业务或服务的Hims & Hers（HIMS）、WW International（WW）和GoodRx Holdings（GDRX）等公司带来影响。 在GLP-1药物领域，制药巨头礼来（LLY）与诺和诺德长期处于激烈竞争中 ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

The glucagon-like peptide 1 (GLP-1) market is poised for growth due to rising diabetes and obesity rates, expanded therapy ...

Novo Nordisk A/S (NYSE: NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

Ozempic may be more expensive and harder to find now that compounded semaglutide isn't available. Here are 9 reputable places ...

Patients with a heart failure history and preserved ejection fraction appeared to benefit ...